News

NIH Operates Under a Continuing Resolution

Notice Number: NOT-OD-14-012

Key Dates Release Date: October 25, 2013

Related Announcements NOT-OD-14-007

Issued by National Institutes of Health (NIH)

A new study by University of Kentucky Markey Cancer Center researchers Min Chen and Kathleen O’Connor shows that a specific protein may assist breast cancer cells in metastasizing. Tumor cells escape a primary tumor by a process called invasion. This process of invasion requires cells to migrate or move through tissue.

Revised Guidance on Resumption of NIH Extramural Activities Following the Recent Lapse in Appropriations

Notice Number: NOT-OD-14-007

Key Dates
Release Date: October 22, 2013

Related Announcements
NOT-OD-14-002
NOT-OD-14-003
NOT-OD-14-006

Guidance on Resumption of NIH Extramural Activities Following the Recent Lapse in Appropriations

Notice Number: NOT-OD-14-003

Key Dates
Release Date: October 18, 2013

Related Announcements
NOT-OD-14-002

Issued by
National Institutes of Health (NIH)

Purpose

NIH has released its guidance (see below). OSPA is unable to submit applications at this time. We will provide an update as more information is available.

 http://grants.nih.gov/grants/guide/notice-files/NOT-OD-14-002.html

 Interim Guidance on Resumption of NIH Extramural Activities

Notice Number:NOT-OD-14-002

The University of Kentucky Center for Clinical and Translational Science will host the 2nd Annual UK Clinical Research Education Day on Friday, Oct. 25, from 9 a.m. to 3 p.m. in the UK Chandler Hospital, Pavilion H North Lobby (outside of the administration offices).

NIH Grant Submission Process during the Shutdown eIAF – these should be processed as soon as possible Proposals – do not submit your proposal to OSPA. New deadlines will be established once the Government re-opens. Therefore, proposals need to be ready for submission in response to these deadlines.

CCTS Call for Drug Discovery and Development Applications for Funding of Transformational Team Science
Linda Dwoskin, PhD, Director
Jon Thorson, PhD, Co-Director

Bradley Gelfand, assistant professor in the Department of Ophthalmology and Visual Sciences at the University of Kentucky College of Medicine, has received a $100,000 one-year grant from the International Retinal Research Foundation (IRRF) for his study “Iron-induced Alu RNA stability and toxicity in geographic atrophy.” Gelfand's lab is investigating the integration of two disease causing phenomena -- iron overload and Alu RNA buildup - into one overarching model. "The disease we are studying is geographic atrophy, which is the advanced stage of ‘dry’ age-related macular degeneration," Ge

The University of Kentucky Center for Clinical and Translational Science (CCTS) Pilot Funding Program announces recipients of its most recent round of pilot funding in the Collaborative Category.

Notice Number: NOT-OD-13-126

Release Date: October 1, 2013

Issued by
National Institutes of Health (NIH)

Purpose

I am very pleased to announce a new cycle of funding opportunities for pilot projects in cancer research under an Institutional Research Grant to the University of Kentucky from the American Cancer Society.  This grant is awarded to the University "... to provide 'seed' money awards for the initiation of promising new projects [in cancer research] by junior faculty members (Assistant Professors or their equivalent, not currently funded), so they can obtain preliminary results that will enable them to compete successfully for national research grants." 

It’s now possible for those without SAP access, including PIs, to track the routing status of eIAFs.  Here is the announcement distributed in last week’s Grants Bulletin by the Office of Sponsored Project Administration.  

Investigator eIAF Tracking Report Instructions

The bodies of mammals, including humans, respond to injury by releasing endogenous opioids — compounds that mitigate acute pain. A team of researchers, led by those at the University of Kentucky, has uncovered groundbreaking new information about how the body responds to traumatic injury with the development of a surprisingly long-lasting opioid mechanism of natural chronic pain control. Remarkably, the body develops both physical and physiological dependence on this opioid system, just as it does on opiate narcotic drugs.

Attention Investigators

The University of Kentucky Gill Heart Institute and the UK Saha Cardiovascular Research Center will host the 16th Annual Gill Heart Cardiovascular Research Day, Oct. 11, at the Lexington Convention Center. Gill Heart Insitute Cardiovascular Research Day annually attracts preeminent speakers in the field of cardiology and cardiovascular research. It also features a symposium for trainee researchers, a scientific poster session, and the presentation of the annual Saha Awards for medical and nursing education. This year, speakers include Dr.

NIH offers a large a variety of social media outlets to help investigators stay informed.  Follow this link to a summary page of the many outlets NIH is using to increase communication.   

From NIH Email - NIH eSubmission Items of Interest - August 21, 2013

Are you ready for our move to updated electronic application forms (FORMS-C)?

We’ve been busy preparing for our transition to updated application forms for most grant programs (NOT-OD-13-074). Our FOAs now have FORMS-C application packages and old B1 and B2 packages have been set to expire.

Here are some updated resources you may want to check out:

The NIH webinar, “Using ASSIST to Prepare and Submit Multi-Project Applications to NIH,” as presented on August 13 is now available for viewing at the following link:  http://grants.nih.gov/grants/webinar_docs/webinar_20130813.htm.  If you are thinking of submitting a multi-project application for an upcoming deadline, take some time to view this presentation and/or the associated PowerPoint slides also available at this link.  NIH will require electronic submission for all P01, P20, P50 and U19 appl

You may not know the human metapneumovirus by name, but chances are that you have met somewhere before.

HMPV, as it's known to virologists, is a common respiratory virus that new studies suggest is second only to influenza in the number of viral pneumonia cases it causes worldwide every year. Especially dangerous for small children, the elderly, and anyone with a compromised immune system, the virus strikes almost 100 percent of people on Earth at some point in their lives.